pLenti_P2A_Puro Citations (2)

Originally described in: The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferent.
Middelburg J, Ghaffari S, Schoufour TAW, Sluijter M, Schaap G, Goynuk B, Sala BM, Al-Tamimi L, Scheeren F, Franken KLMC, Akkermans JJLL, Cabukusta B, Joosten SA, Derksen I, Neefjes J, van der Burg SH, Achour A, Wijdeven RHM, Weidanz J, van Hall T Cell Rep. 2023 Dec 26;42(12):113516. doi: 10.1016/j.celrep.2023.113516. Epub 2023 Dec 3. PubMed Journal

---

Articles Citing pLenti_P2A_Puro

Articles
CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognition. Schoufour TAW, van der Plas-van Duijn A, Derksen I, Melgers M, van Veenendaal JMF, Lensen C, Heemskerk MHM, Neefjes J, Wijdeven RHM, Scheeren FA. iScience. 2024 May 27;27(6):110120. doi: 10.1016/j.isci.2024.110120. eCollection 2024 Jun 21. PubMed
CRISPR activation screen uncovers MARCKSL1 as a gauge for extracellular vesicle secretion. Zhong Y, George AE, Koning RI, Liv N, de Heus C, Tjokrodirijo RTN, Messchendorp M, Akkermans JJL, Cabukusta B, Janssen GMC, van Veelen PA, Wijdeven RHM, Neefjes J, Verweij FJ, Berlin I. Cell Rep. 2026 Jul 31;45(8):117744. doi: 10.1016/j.celrep.2026.117744. PubMed

If you have published an article using this material, please email us at to have your article added to this page.